![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Rothschedl, E. and Nachtnebel, A. (2015): Horizon Scanning in Oncology: Results of the 24th Prioritisation – 3rd quarter 2015. HSO: 24th Prioritisation.
Preview |
PDF
- Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
288kB |
Abstract
For the 24th prioritisation (September 2015), 7 were filtered out of 191 identified drugs and were sent to prioritisation. Of these, 2 drugs were ranked as 'highly relevant' by the expert panel, 4 as 'relevant' and 1 as 'not relevant'. For 'highly relevant' drugs, further information including, for example, abstracts of phase III studies and licensing status is contained in this document.
| Item Type: | DSD: Horizon Scanning in Oncology |
|---|---|
| Subjects: | WB Practice of medicine > WB 300-962 Therapeutics QZ Pathology > QZ 200-380 Neoplasms.Cysts |
| Language: | English |
| Series Name: | HSO: 24th Prioritisation |
| Deposited on: | 03 Nov 2015 15:26 |
| Last Modified: | 15 Jul 2020 17:53 |
Repository Staff Only: item control page